Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company uses anti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California.